Feasibility, toxicity and response of upfront metaiodobenzylguanidine therapy therapy followed by German Pediatric Oncology Group Neuroblastoma 2004 protocol in newly diagnosed stage 4 neuroblastoma patients
-
Published:2017-05
Issue:
Volume:76
Page:188-196
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Kraal K.C.J.M.,
Bleeker G.M.,
van Eck-Smit B.L.F.ORCID,
van Eijkelenburg N.K.A.ORCID,
Berthold F.,
van Noesel M.M.,
Caron H.N.,
Tytgat G.A.M.
Subject
Cancer Research,Oncology
Reference29 articles.
1. Trends in cancer incidence among children in the U.S;Gurney;Cancer,1996
2. Treatment and outcomes of patients with relapsed, high-risk neuroblastoma: results of German trials;Simon;Pediatr Blood Cancer,2011
3. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group;Matthay;N Engl J Med,1999
4. Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma;Yu;N Engl J Med,2010
5. Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial;Berthold;Lancet Oncol,2005
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献